天新药业: 独立董事专门会议工作制度

Core Points - The document outlines the working system for independent director special meetings at Jiangxi Tianxin Pharmaceutical Co., Ltd, emphasizing the importance of independent directors in corporate governance [1][4] - The system is established in accordance with relevant laws and regulations, including the Company Law of the People's Republic of China and the Shanghai Stock Exchange's self-regulatory guidelines [1][4] Group 1: Meeting Procedures - Independent director special meetings can be convened as needed to discuss various company matters, with a requirement for notification at least three days in advance [1][4] - The meetings must be attended by at least half of the independent directors, and decisions require a majority vote [1][4][3] - Meetings can be held in person or through various communication methods, and independent directors must personally attend or delegate their voting rights [1][4] Group 2: Responsibilities and Authority - Certain matters must be discussed and approved by the independent director special meeting before being submitted to the board, including related party transactions and changes to commitments [1][4] - Independent directors have the authority to hire external consultants for audits or consultations, propose temporary shareholder meetings, and call board meetings [1][4] Group 3: Documentation and Confidentiality - Meetings must have written records that include details such as time, location, attendees, proposals, and voting results [1][4][3] - Independent directors are bound by confidentiality regarding the matters discussed in the meetings and must not disclose any related information [1][4]